Elanco Animal Health Stock Filter Stocks by Fundamentals
ELAN Stock | USD 13.13 0.26 1.94% |
Elanco Animal Health fundamentals help investors to digest information that contributes to Elanco Animal's financial success or failures. It also enables traders to predict the movement of Elanco Stock. The fundamental analysis module provides a way to measure Elanco Animal's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Elanco Animal stock.
Elanco | Cash and Equivalents |
Did you try this?
Run Pattern Recognition Now
Pattern RecognitionUse different Pattern Recognition models to time the market across multiple global exchanges |
All Next | Launch Module |
Elanco Animal ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Elanco Animal's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Elanco Animal's managers, analysts, and investors.Environmental | Governance | Social |
Elanco Fundamentals
Return On Equity | 0.0324 | ||||
Return On Asset | 0.0118 | ||||
Profit Margin | 0.05 % | ||||
Operating Margin | (0) % | ||||
Current Valuation | 10.36 B | ||||
Shares Outstanding | 494.35 M | ||||
Shares Owned By Insiders | 0.65 % | ||||
Shares Owned By Institutions | 98.90 % | ||||
Number Of Shares Shorted | 15.16 M | ||||
Price To Earning | 241.75 X | ||||
Price To Book | 1.00 X | ||||
Price To Sales | 1.46 X | ||||
Revenue | 4.42 B | ||||
Gross Profit | 2.5 B | ||||
EBITDA | (224 M) | ||||
Net Income | (1.23 B) | ||||
Cash And Equivalents | 463 M | ||||
Cash Per Share | 0.98 X | ||||
Total Debt | 5.77 B | ||||
Debt To Equity | 0.87 % | ||||
Current Ratio | 1.96 X | ||||
Book Value Per Share | 13.20 X | ||||
Cash Flow From Operations | 271 M | ||||
Short Ratio | 3.20 X | ||||
Earnings Per Share | 0.41 X | ||||
Price To Earnings To Growth | 1.84 X | ||||
Target Price | 17.84 | ||||
Number Of Employees | 9.3 K | ||||
Beta | 1.42 | ||||
Market Capitalization | 6.49 B | ||||
Total Asset | 14.36 B | ||||
Retained Earnings | (2.29 B) | ||||
Working Capital | 2.17 B | ||||
Current Asset | 2.45 B | ||||
Current Liabilities | 805.47 M | ||||
Net Asset | 14.36 B |
About Elanco Animal Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Elanco Animal Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Elanco Animal using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Elanco Animal Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Elanco Animal
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Elanco Animal position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elanco Animal will appreciate offsetting losses from the drop in the long position's value.Moving against Elanco Stock
0.71 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
0.58 | KB | KB Financial Group | PairCorr |
0.49 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
0.41 | ITCL | Banco Ita Chile | PairCorr |
0.33 | CIB | Bancolombia SA ADR | PairCorr |
The ability to find closely correlated positions to Elanco Animal could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Elanco Animal when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Elanco Animal - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Elanco Animal Health to buy it.
The correlation of Elanco Animal is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Elanco Animal moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Elanco Animal Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Elanco Animal can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Elanco Animal Piotroski F Score and Elanco Animal Altman Z Score analysis. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Elanco Animal. If investors know Elanco will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Elanco Animal listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.71) | Earnings Share 0.41 | Revenue Per Share 9.023 | Quarterly Revenue Growth (0.04) | Return On Assets 0.0118 |
The market value of Elanco Animal Health is measured differently than its book value, which is the value of Elanco that is recorded on the company's balance sheet. Investors also form their own opinion of Elanco Animal's value that differs from its market value or its book value, called intrinsic value, which is Elanco Animal's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Elanco Animal's market value can be influenced by many factors that don't directly affect Elanco Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Elanco Animal's value and its price as these two are different measures arrived at by different means. Investors typically determine if Elanco Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Elanco Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.